Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$89,500
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gengos Andrew +$90K Chief Financial Officer 1 filing

Reading 43 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-13 BERMAN ANN E Director Grant or award · Stock Option +33,350 33,350
2025-01-01 BERMAN ANN E Director Grant or award · Stock Option +23,485 23,485
2025-01-01 BERMAN ANN E Director Grant or award · Stock Option +17,614 17,614
2024-06-12 BERMAN ANN E Director Grant or award · Stock Option +33,350 33,350
2024-03-18 BERMAN ANN E Director Purchase +57,965 $2.13 $123K 67,465
2023-06-14 BERMAN ANN E Director Grant or award · Stock Option +17,500 17,500

Page 1 of 1 · 6 trades